These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2583259)

  • 1. Primarily asymptomatic low-grade non-Hodgkin lymphomas: prediction of symptom-free survival and total survival.
    Martinsson U; Glimelius B; Hagberg H; Sundström C
    Eur J Haematol; 1989 Oct; 43(4):332-8. PubMed ID: 2583259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic relevance of serum-markers in relation to histopathology, stage and initial symptoms in advanced low-grade non-Hodgkin lymphomas.
    Martinsson U; Glimelius B; Hagberg H; Sundström C
    Eur J Haematol; 1988 Apr; 40(4):289-98. PubMed ID: 3366218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Aggressive' low grade lymphocytic lymphomas can be identified by flow cytometric S-phase determinations.
    Lindh J; Jonsson H; Lenner P; Roos G
    Hematol Oncol; 1992; 10(3-4):171-9. PubMed ID: 1398513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum thymidine kinase in non-Hodgkin lymphomas with special regard to multiple myeloma.
    Poley S; Stieber P; Nüssler V; Pahl H; Fateh-Moghadam A
    Anticancer Res; 1997; 17(4B):3025-9. PubMed ID: 9329592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of serum thymidine kinase in non-Hodgkin lymphoma: relationship to other prognostic factors.
    Hallek M; Emmerich B; Strohmeyer S; Busch R; Reichle A; Senekowitsch R
    Klin Wochenschr; 1988 Aug; 66(16):718-23. PubMed ID: 3172680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of serum lactic dehydrogenase levels and fraction of S-phase cells in non-Hodgkin lymphomas.
    Lindh J; Lenner P; Osterman B; Roos G
    Eur J Haematol; 1993 May; 50(5):258-63. PubMed ID: 8319787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers in non-Hodgkin's lymphoma stages III and IV and prognosis: a multivariate analysis.
    Hagberg H; Glimelius B; Gronowitz S; Killander A; Källander C; Schröder T
    Scand J Haematol; 1984 Jul; 33(1):59-67. PubMed ID: 6379852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary non-Hodgkin's lymphomas of the female breast.
    Giardini R; Piccolo C; Rilke F
    Cancer; 1992 Feb; 69(3):725-35. PubMed ID: 1730123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic parameters in low-grade non-Hodgkin's lymphomas.
    Zemunik T; Vucković J; Forenpoher G; Knezević N; Stula N; Dubravcić M; Ribicić I; Rozga A
    Neoplasma; 1997; 44(1):13-7. PubMed ID: 9201275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
    Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
    Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxythymidine kinase in the tumour cells and serum of patients with non-Hodgkin lymphomas.
    Rehn S; Gronowitz JS; Källander C; Sundström C; Glimelius B
    Br J Cancer; 1995 May; 71(5):1099-105. PubMed ID: 7734308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Low-grade malignant non-Hodgkin lymphomas--current status and trends in therapy].
    Hiddemann W
    Ther Umsch; 1996 Feb; 53(2):123-32. PubMed ID: 8629262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of proliferation-associated parameters in B-cell non-Hodgkin lymphoma.
    Rehn S; Glimelius B; Sundström C
    Hematol Oncol; 1991; 9(6):287-98. PubMed ID: 1748395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
    Akerman M; Brandt L; Johnson A; Olsson H
    Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of flow cytometry studies in B-cell non-Hodgkin lymphoma.
    Rehn S; Glimelius B; Strang P; Sundström C; Tribukait B
    Hematol Oncol; 1990; 8(1):1-12. PubMed ID: 2298418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
    Kok M; Bonfrer JM; Korse CM; de Jong D; Kersten MJ
    Tumour Biol; 2003; 24(1):53-60. PubMed ID: 12743427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent Lymphomas That Present With Clinically Aggressive Features: A Subset of Low-Grade Lymphomas With a Behavior Inconsistent With the Histologic Diagnosis.
    Cabanillas F; Rivera N; Pardo WI
    Clin Lymphoma Myeloma Leuk; 2016 Oct; 16(10):550-557. PubMed ID: 27618361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of advanced stage low grade follicular lymphomas in a population-based retrospective cohort.
    Wood LA; Coupland RW; North SA; Palmer MC
    Cancer; 1999 Mar; 85(6):1361-8. PubMed ID: 10189143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
    Heinz R; Hanak H; Stacher A
    Klin Wochenschr; 1985 Jul; 63(14):619-26. PubMed ID: 3839867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.